Profilo
David Apelian is currently Chief Executive Officer at Theolytics Ltd. since 2024.
Formerly, Chief Executive Officer & Director at Eiger BioPharmaceuticals, Inc. from 2022 to 2024, Chief Executive Officer & Director at BlueSphere Bio, Inc. from 2019 to 2022, Chief Medical Officer & Executive Vice President at Achillion Pharmaceuticals, Inc. from 2013 to 2017, Chief Medical Officer, SVP-Research & Development at GlobeImmune, Inc. from 2008 to 2013, Clinical Director-Infectious Diseases Group at Bristol Myers Squibb Co. from 2002 to 2004, Clinical Director-Hepatology Department at Schering-Plough Corp.
from 1999 to 2002, and Vice President at Wyeth Pharmaceuticals LLC.
Education includes a doctorate from the University of Medicine & Dentistry of New Jersey, undergraduate and doctorate degrees from Rutgers State University of New Jersey, and an MBA from Quinnipiac University.
Posizioni attive di David Apelian
| Società | Posizione | Inizio |
|---|---|---|
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Amministratore Delegato | 17/12/2024 |
Precedenti posizioni note di David Apelian
| Società | Posizione | Fine |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Amministratore Delegato | 01/09/2024 |
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs products | Amministratore Delegato | 04/10/2022 |
| ACHILLION PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 28/12/2017 |
| GLOBEIMMUNE, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2013 |
| BRISTOL-MYERS SQUIBB COMPANY | Direttore Tecnico/Scientifico/R&S | - |
Formazione di David Apelian
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
GlobeImmune, Inc.
GlobeImmune, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutic products for cancer and infectious diseases | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
University of Medicine & Dentistry of New Jersey
University of Medicine & Dentistry of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quinnipiac University
Quinnipiac University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
BlueSphere Bio, Inc.
BlueSphere Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs products | Health Technology |
















